We are almost there ...
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
11 February, 2025•10 min
0
11 February, 2025•10 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
India’s business next-gen a lazy and unambitious lot? Not really.
Uday Kotak says heirs are choosing to manage family money rather than run real businesses. This lament doesn’t stand scrutiny.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Internet
India declines to participate in PISA in 2025, yet again
For a country aspiring to be a superpower, with more than 250 million children in schools, India’s reluctance to participate in an international student assessment study is confounding.
Internet
India’s Faustian deal with Tesla
In paving the way for Tesla to sell its cars in the country with reduced duties, India comes across as partisan and a country that can be bullied into acting against its own interests.